Wall Street brokerages forecast that Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI) will announce earnings of ($0.47) per share for the current quarter, Zacks reports. Zero analysts have provided estimates for Checkmate Pharmaceuticals’ earnings. The lowest EPS estimate is ($0.49) and the highest is ($0.44). The firm is scheduled to report its next quarterly...
Read Full StoryTop News
Related
DISEASE PREVENTION AND TREATMENT
I-Team: Cases at long-term care facilities sharply decrease
, 3min
0
, 5min
0
Maryland Senators return to full strength after receiving “false positive” on rapid covid test
, 6min
0